These data, paired with miR-708-5p targeting of NNAT and CD276, provide strong evidence for miR-708-5p as a tumor suppressor in breast cancer through repression of invasion, proliferation, and potentially immune modulation. The gene discussed is CD276; the disease is breast cancer.